Home

Solution

Solution

How mIHC Transforms Drug Development and Clinical Pathology

How mIHC Transforms Drug Development and Clinical Pathology

How mIHC Transforms Drug Development and Clinical Pathology

"Discover how mIHC revolutionizes drug development & pathology—multiplex biomarker detection for precise diagnostics & faster research insights."

Advantages of mIHC Over Traditional IHC in Drug Development

mihc

Advantages of mIHC Over Traditional IHC in Drug Development

Discover how mIHC outperforms traditional IHC in drug development—saving time, reducing costs, and enhancing biomarker discovery. Learn more!

Automating Multiplex Immunohistochemistry: Boosting Lab Efficiency

mihc

Automating Multiplex Immunohistochemistry: Boosting Lab Efficiency

Discover how Celnovte's automated mIHC stainer boosts lab efficiency with consistent, high-throughput multiplex staining for cancer & immune research.

Validated IHC Biomarkers for ADC Therapy – Celnovte ADC Companion Diagnostic Antibodies

Validated IHC Biomarkers for ADC Therapy – Celnovte ADC Companion Diagnostic Antibodies

Explore Celnovte’s clinically validated IHC antibody series for ADC companion diagnostics. Designed for HER2, TROP2, FRα, c-Met, and more ADC targets across cancer types.

top